[Complications with synthetic antimalarials].
D000962:Antimalarials / Q000009:adverse effects*; D001247:Asthenia / Q000139:chemically induced*; D002493:Central Nervous System Diseases / Q000139:chemically induced*; D002738:Chloroquine / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology*; D004485:Eczema / Q000188:drug therapy; D005128:Eye Diseases / Q000139:chemically induced*; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D006402:Hematologic Diseases / Q000139:chemically induced*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D010859:Pigmentation Disorders / Q000139:chemically induced; D011565:Psoriasis / Q000188:drug therapy; D011796:Quinacrine / Q000009:adverse effects; D012871:Skin Diseases / Q000188:drug therapy*
D000962:Antimalarials; D002738:Chloroquine; D011796:Quinacrine
Incidents des antipaludéens de synthèse.